HOXB13 and prostate cancer: Specifically, several missense rare mutations in HOXB13, including G84E, Y88D, L144P, G216C, and R229G, have been identified in association with increased prostate cancer susceptibility through targeted germline DNA sequencing of the 17q21-22 region in a cohort of 94 prostate cancer patients [22].